TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2025 Earnings Call Transcript March 5, 2026 TriSalus Life Sciences, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.13.

For over 5 years, Arthur has been professionally covering video games, writing guides and walkthroughs. His passion for video games began at age 10 in 2010 when he first played Gothic, an immersive ...

Wasatch Global Investors, an asset management company, released its “Global Select Strategy” Q4 2025 investor letter. The Wasatch Global Select Strategy underperformed its benchmark in Q4 2025 despite ...

RS Investments, an investment management company, released its fourth-quarter 2025 investor letter for “RS Large Cap Value Strategy”. The RS Value team seeks to invest in profitable companies with ...

The 13th annual report reveals a 24% income gap between strategic leaders and ICs, while new data shows hands-on AI usage is the only cure for career anxiety. REHOVOT ...

NEW YORK, Feb. 11, 2026 /PRNewswire/ -- Level2, a fully visual, no-code platform for trading strategy creation and automation, today announced a partnership with Public, the long-term investing ...